title: [High-dose urokinase for thrombolysis following replantation of severed limbs or fingers].
abstract: OBJECTIVE
  To study the efficacy of intravenous urokinase administration in preventing and treating vascular crisis in limb or finger replantation (LFR).
  
  
  METHODS
  From September, 1999 to October, 2003, 158 patients underwent RSLF in whom 600,000 U of urokinase diluted in 30 ml saline was injected intravenously after blood vessel suture. An intermittent dose (200,000 U) per 12 h given postoperatively for maintenance. A large dose of 1,000,000-1,500,000 U of urokinase was used in the event of vascular crisis. The D-dimer, fibrinogen, hematin, and blood platelet were measured in these patients before and after urokinase administration.
  
  
  RESULTS
  Vascular crisis was not observed in 117 patients (74.1%) undergoing LFR, and in the 41 patients who developed vascular crisis, relief was achieved by high-dose urokinase (90.2%) with failure occurring in only 4 cases (one with wrist and 3 with finger replantation) for whom re-operation was required. The result was better than those in relevant reports.
  
  
  CONCLUSIONS
  A moderate dose of urokinase can be used after suturing the vessels and intermittent small doses prove feasible postoperatively to prevent thrombosis in RSLF. A high dose of urokinase can be safely used for vascular crisis management in the early stage.
authors.affiliation: Department of Microsurgery, Fangshuquan Hospital, Dongguan 523945, China. myhct@medmail.com.cn
authors.forename: Chao-tong
authors.initials: CT
authors.lastname: Huang
authors.forename: Jing-kuang
authors.initials: JK
authors.lastname: Li
authors.forename: Jia-kai
authors.initials: JK
authors.lastname: Zhu
authors.forename: Xiao-qiang
authors.initials: XQ
authors.lastname: Lu
authors.forename: Qing-yu
authors.initials: QY
authors.lastname: Li
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D005383:Finger Injuries / Q000188:drug therapy* / Q000601:surgery*; D006230:Hand Injuries / Q000601:surgery; D006801:Humans; D008297:Male; D019990:Perioperative Care; D011184:Postoperative Period; D012092:Replantation; D015912:Thrombolytic Therapy; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D014568:Urokinase-Type Plasminogen Activator